The Caryl and Israel Englander Institute for Precision Medicine at Weill Cornell Medicine emphasizes collaboration, ensuring that the institute can provide genomics support to a range of clinical programs at Weill Cornell Medicine and NewYork-Presbyterian, such as the Weill Cornell Leukemia Program and the Weill Cornell Breast Center, as well as Weill Cornell research hubs including the The Sandra and Edward Meyer Cancer CenterCardiovascular Research Institute and the Gale and Ira Drukier Institute for Children’s Health.

In addition to the above, the Englander Institute for Precision Medicine has established collaborations with the NYGC, All of Us and EuroPDX.

Our collaborators include researchers in the WCM/NYP community, as well as investigators at other universities and in the biotechnology and pharmaceutical industries.

As next-generation sequencing technologies have made it possible to generate high-resolution genomic data much more efficiently, researchers in many fields have turned to next-generation sequencing to identify particular features of the genome that contribute to specific phenotypes.

We utilize techniques from computer science, statistics, and information theory to infer the relationships and dynamics among genes and to develop predictive models that identify factors within cell regulatory networks that are important in generating specific phenotypes.

In the context of translational research, these key factors could ultimately be targets for treatment.

Our tools for performing these analyses include an array of algorithms and software that were developed by investigators in the Department of Computational Biomedicine in Physiology and BiophysicsWe believe that working collaboratively dramatically improves not only what we do, but helps others do the same.

To this end, we partner with organizations who share our mission and passion for helping further disease research and results in more efficient patient treatments.

We are very proud of our network of partnerships and alliances with various groups and institutions, as well as the grant awards we have received, that allow us to continue our work. These are central to our ability to deliver the best solutions to patients, so they can achieve the highest quality of life possible. 

The Englander Institute for Precision Medicine is eagerly growing an interconnection of researchers, clinicians, and institutions whereby we can all share resources and important data.

If you are interested in joining our Precision Medicine Working Group, please contact us about being added to our expanding network and regular meetings.

Together we can overcome barriers and work across organizational boundaries to enable cutting-edge discoveries and reach the highest possibilities in improving health for all.